Tg Therapeutics (TGTX) Change in Inventory (2023 - 2026)

Tg Therapeutics' Change in Inventory history runs 4 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 71.33% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $422000.0, a 99.45% decrease from a year earlier, with the FY2025 full-year figure at $33.5 million, down 49.96% from the prior year.
• Change in Inventory climbed to $13.3 million in Q1 2026 per TGTX's latest filing, from -$563000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $46.3 million in Q1 2025 and bottomed at -$8.7 million in Q3 2025.
• The 4-year median for Change in Inventory is $2.6 million (2024), against an average of $11.6 million.
• Across the five-year window, Change in Inventory jumped 350.78% in 2024 and plunged 442.32% in 2025, its largest moves.
• Year by year, Change in Inventory stood at $5.5 million in 2023, then soared by 350.78% to $24.8 million in 2024, then slumped by 102.27% to -$563000.0 in 2025, then soared by 2457.9% to $13.3 million in 2026.
• Per Business Quant, the three latest TGTX Change in Inventory figures stand at $13.3 million (Q1 2026), -$563000.0 (Q4 2025), and -$8.7 million (Q3 2025).